Triazine derivatives and their use in the treatment of cancer.

RS68198B1Active Publication Date: 2026-06-30F HOFFMANN LA ROCHE & CO AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
RS68198P0
Authority / Receiving Office
RS · RS
Patent Type
Patents
Current Assignee / Owner
Priority Date
2022-06-02
Filing Date
2022-06-02
Publication Date
2026-06-30
Estimated Expiration
2042-06-02
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.